Literature DB >> 21664998

The orphan disease networks.

Minlu Zhang1, Cheng Zhu2, Alexis Jacomy3, Long J Lu4, Anil G Jegga5.   

Abstract

The low prevalence rate of orphan diseases (OD) requires special combined efforts to improve diagnosis, prevention, and discovery of novel therapeutic strategies. To identify and investigate relationships based on shared genes or shared functional features, we have conducted a bioinformatic-based global analysis of all orphan diseases with known disease-causing mutant genes. Starting with a bipartite network of known OD and OD-causing mutant genes and using the human protein interactome, we first construct and topologically analyze three networks: the orphan disease network, the orphan disease-causing mutant gene network, and the orphan disease-causing mutant gene interactome. Our results demonstrate that in contrast to the common disease-causing mutant genes that are predominantly nonessential, a majority of orphan disease-causing mutant genes are essential. In confirmation of this finding, we found that OD-causing mutant genes are topologically important in the protein interactome and are ubiquitously expressed. Additionally, functional enrichment analysis of those genes in which mutations cause ODs shows that a majority result in premature death or are lethal in the orthologous mouse gene knockout models. To address the limitations of traditional gene-based disease networks, we also construct and analyze OD networks on the basis of shared enriched features (biological processes, cellular components, pathways, phenotypes, and literature citations). Analyzing these functionally-linked OD networks, we identified several additional OD-OD relations that are both phenotypically similar and phenotypically diverse. Surprisingly, we observed that the wiring of the gene-based and other feature-based OD networks are largely different; this suggests that the relationship between ODs cannot be fully captured by the gene-based network alone.
Copyright © 2011 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21664998      PMCID: PMC3113244          DOI: 10.1016/j.ajhg.2011.05.006

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  38 in total

1.  Towards a proteome-scale map of the human protein-protein interaction network.

Authors:  Jean-François Rual; Kavitha Venkatesan; Tong Hao; Tomoko Hirozane-Kishikawa; Amélie Dricot; Ning Li; Gabriel F Berriz; Francis D Gibbons; Matija Dreze; Nono Ayivi-Guedehoussou; Niels Klitgord; Christophe Simon; Mike Boxem; Stuart Milstein; Jennifer Rosenberg; Debra S Goldberg; Lan V Zhang; Sharyl L Wong; Giovanni Franklin; Siming Li; Joanna S Albala; Janghoo Lim; Carlene Fraughton; Estelle Llamosas; Sebiha Cevik; Camille Bex; Philippe Lamesch; Robert S Sikorski; Jean Vandenhaute; Huda Y Zoghbi; Alex Smolyar; Stephanie Bosak; Reynaldo Sequerra; Lynn Doucette-Stamm; Michael E Cusick; David E Hill; Frederick P Roth; Marc Vidal
Journal:  Nature       Date:  2005-09-28       Impact factor: 49.962

2.  A human protein-protein interaction network: a resource for annotating the proteome.

Authors:  Ulrich Stelzl; Uwe Worm; Maciej Lalowski; Christian Haenig; Felix H Brembeck; Heike Goehler; Martin Stroedicke; Martina Zenkner; Anke Schoenherr; Susanne Koeppen; Jan Timm; Sascha Mintzlaff; Claudia Abraham; Nicole Bock; Silvia Kietzmann; Astrid Goedde; Engin Toksöz; Anja Droege; Sylvia Krobitsch; Bernhard Korn; Walter Birchmeier; Hans Lehrach; Erich E Wanker
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

3.  Predicting disease genes using protein-protein interactions.

Authors:  M Oti; B Snel; M A Huynen; H G Brunner
Journal:  J Med Genet       Date:  2006-04-12       Impact factor: 6.318

4.  Adopting orphan drugs--two dozen years of treating rare diseases.

Authors:  Marlene E Haffner
Journal:  N Engl J Med       Date:  2006-02-02       Impact factor: 91.245

5.  Are rare diseases still orphans or happily adopted? The challenges of developing and using orphan medicinal products.

Authors:  James W Dear; Pajaree Lilitkarntakul; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

6.  Why do mutations in the ubiquitously expressed housekeeping gene IMPDH1 cause retina-specific photoreceptor degeneration?

Authors:  Sara J Bowne; Qin Liu; Lori S Sullivan; Jingya Zhu; Catherine J Spellicy; Catherine Bowes Rickman; Eric A Pierce; Stephen P Daiger
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-09       Impact factor: 4.799

7.  Further understanding human disease genes by comparing with housekeeping genes and other genes.

Authors:  Zhidong Tu; Li Wang; Min Xu; Xianghong Zhou; Ting Chen; Fengzhu Sun
Journal:  BMC Genomics       Date:  2006-02-21       Impact factor: 3.969

8.  Reactome: a knowledgebase of biological pathways.

Authors:  G Joshi-Tope; M Gillespie; I Vastrik; P D'Eustachio; E Schmidt; B de Bono; B Jassal; G R Gopinath; G R Wu; L Matthews; S Lewis; E Birney; L Stein
Journal:  Nucleic Acids Res       Date:  2005-01-01       Impact factor: 16.971

9.  The Biomolecular Interaction Network Database and related tools 2005 update.

Authors:  C Alfarano; C E Andrade; K Anthony; N Bahroos; M Bajec; K Bantoft; D Betel; B Bobechko; K Boutilier; E Burgess; K Buzadzija; R Cavero; C D'Abreo; I Donaldson; D Dorairajoo; M J Dumontier; M R Dumontier; V Earles; R Farrall; H Feldman; E Garderman; Y Gong; R Gonzaga; V Grytsan; E Gryz; V Gu; E Haldorsen; A Halupa; R Haw; A Hrvojic; L Hurrell; R Isserlin; F Jack; F Juma; A Khan; T Kon; S Konopinsky; V Le; E Lee; S Ling; M Magidin; J Moniakis; J Montojo; S Moore; B Muskat; I Ng; J P Paraiso; B Parker; G Pintilie; R Pirone; J J Salama; S Sgro; T Shan; Y Shu; J Siew; D Skinner; K Snyder; R Stasiuk; D Strumpf; B Tuekam; S Tao; Z Wang; M White; R Willis; C Wolting; S Wong; A Wrong; C Xin; R Yao; B Yates; S Zhang; K Zheng; T Pawson; B F F Ouellette; C W V Hogue
Journal:  Nucleic Acids Res       Date:  2005-01-01       Impact factor: 16.971

10.  Consolidating the set of known human protein-protein interactions in preparation for large-scale mapping of the human interactome.

Authors:  Arun K Ramani; Razvan C Bunescu; Raymond J Mooney; Edward M Marcotte
Journal:  Genome Biol       Date:  2005-04-15       Impact factor: 13.583

View more
  27 in total

Review 1.  Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review.

Authors:  Peter Csermely; Tamás Korcsmáros; Huba J M Kiss; Gábor London; Ruth Nussinov
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

Review 2.  Systems biology for molecular life sciences and its impact in biomedicine.

Authors:  Miguel Ángel Medina
Journal:  Cell Mol Life Sci       Date:  2012-08-19       Impact factor: 9.261

Review 3.  Network medicine: linking disorders.

Authors:  Rosario M Piro
Journal:  Hum Genet       Date:  2012-07-24       Impact factor: 4.132

4.  Applying Systems Biology Methodology To Identify Genetic Factors Possibly Associated with Recovery after Traumatic Brain Injury.

Authors:  Brad G Kurowski; Amery Treble-Barna; Alexis J Pitzer; Shari L Wade; Lisa J Martin; Ranjit S Chima; Anil Jegga
Journal:  J Neurotrauma       Date:  2017-05-03       Impact factor: 5.269

5.  Gene-disease associations identify a connectome with shared molecular pathways in human cholangiopathies.

Authors:  Zhenhua Luo; Anil G Jegga; Jorge A Bezerra
Journal:  Hepatology       Date:  2018-01-02       Impact factor: 17.425

6.  A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19.

Authors:  Yadi Zhou; Yuan Hou; Jiayu Shen; Reena Mehra; Asha Kallianpur; Daniel A Culver; Michaela U Gack; Samar Farha; Joe Zein; Suzy Comhair; Claudio Fiocchi; Thaddeus Stappenbeck; Timothy Chan; Charis Eng; Jae U Jung; Lara Jehi; Serpil Erzurum; Feixiong Cheng
Journal:  PLoS Biol       Date:  2020-11-06       Impact factor: 8.029

7.  Proteome-Scale Investigation of Protein Allosteric Regulation Perturbed by Somatic Mutations in 7,000 Cancer Genomes.

Authors:  Qiancheng Shen; Feixiong Cheng; Huili Song; Weiqiang Lu; Junfei Zhao; Xiaoli An; Mingyao Liu; Guoqiang Chen; Zhongming Zhao; Jian Zhang
Journal:  Am J Hum Genet       Date:  2016-12-08       Impact factor: 11.025

8.  Studying tumorigenesis through network evolution and somatic mutational perturbations in the cancer interactome.

Authors:  Feixiong Cheng; Peilin Jia; Quan Wang; Chen-Ching Lin; Wen-Hsiung Li; Zhongming Zhao
Journal:  Mol Biol Evol       Date:  2014-05-31       Impact factor: 16.240

9.  Increased burden of deleterious variants in essential genes in autism spectrum disorder.

Authors:  Xiao Ji; Rachel L Kember; Christopher D Brown; Maja Bućan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-12       Impact factor: 11.205

10.  Topological network measures for drug repositioning.

Authors:  Apurva Badkas; Sébastien De Landtsheer; Thomas Sauter
Journal:  Brief Bioinform       Date:  2021-07-20       Impact factor: 11.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.